Metabolic mapping of the effects of the antidepressant fluoxetine on the brains of congenitally helpless rats

Brain Research

Volumn 1343, Issue , 2010, Pages 218-225

  Shumake, Jason ^a   Colorado, Rene A ^b   Barrett, Douglas W ^a   Gonzalez Lima, F ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Animal model; Brain mapping; Cytochrome oxidase; Depression; Fluoxetine; Post traumatic stress disorder

Indexed keywords

CYTOCHROME C OXIDASE; FLUOXETINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MAPPING; BRAIN METABOLISM; BRAIN REGION; CLIMBING; CONTROLLED STUDY; DENTATE GYRUS; DRUG EFFECT; ENZYME ACTIVITY; FORCED SWIMMING TEST; HABENULA; HELPLESSNESS; IMMOBILIZATION; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BRAIN; BRAIN MAPPING; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT COMPLEX IV; ENERGY METABOLISM; FLUOXETINE; MALE; RATS; RATS, INBRED STRAINS; SEROTONIN UPTAKE INHIBITORS; SWIMMING;

ANIMALIA; RATTUS;

EID: 77953610179     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.05.015     Document Type: Article

References (44)

1. Blier P., and de Montigny C. Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 21 (1999) 91S-98S
2. Brody A.L., Saxena S., Silverman D.H., Alborzian S., Fairbanks L.A., Phelps M.E., Huang S.C., Wu H.M., Maidment K., and Baxter Jr. L.R. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res. 91 (1999) 127-139
3. Buchsbaum M.S., Wu J., Siegel B.V., Hackett E., Trenary M., Abel L., and Reynolds C. Effect of sertraline on regional metabolic rate in patients with affective disorder, Biol. Psychiatry 41 (1997) 15-22
4. Bymaster F.P., Zhang W., Carter P.A., Shaw J., Chernet E., Phebus L., Wong D.T., and Perry K.W. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology (Berl) 160 (2002) 353-361
5. Caldecott-Hazard S., Mazziotta J., and Phelps M. Cerebral correlates of depressed behavior in rats, visualized using 14C-2-deoxyglucose autoradiography. J. Neurosci. 8 (1988) 1951-1961
6. Detke M.J., Rickels M., and Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121 (1995) 66-72
7. Duman R.S., Malberg J., and Thome J. Neural plasticity to stress and antidepressant treatment, Biol. Psychiatry 46 (1999) 1181-1191
8. Enkel T., Spanagel R., Vollmayr B., and Schneider M. Stress triggers anhedonia in rats bred for learned helplessness. Behav. Brain Res. 209 (2010) 183-186
9. Freo U., Ori C., Dam M., Merico A., and Pizzolato G. Effects of acute and chronic treatment with fluoxetine on regional glucose cerebral metabolism in rats: implications for clinical therapies. Brain Res. 854 (2000) 35-41
10. Gomita Y., and Gallistel C.R. Effects of reinforcement-blocking doses of pimozide on neural systems driven by rewarding stimulation of the MFB: a 14C-2-deoxyglucose analysis. Pharmacol. Biochem. Behav. 17 (1982) 841-845
11. Gonzalez-Lima F., and Cada A. Cytochrome oxidase activity in the auditory system of the mouse: a qualitative and quantitative histochemical study. Neuroscience 63 (1994) 559-578
12. Gonzalez-Pardo H., Conejo N.M., Arias J.L., Monleon S., Vinader-Caerols C., and Parra A. Changes in brain oxidative metabolism induced by inhibitory avoidance learning and acute administration of amitriptyline. Pharmacol. Biochem. Behav. 89 (2008) 456-462
13. Henn F.A., Johnson J., Edwards E., and Anderson D. Melancholia in rodents: neurobiology and pharmacology. Psychopharmacol. Bull. 21 (1985) 443-446
14. Hickie I.B., Scott E.M., and Davenport T.A. Are antidepressants all the same? Surveying the opinions of Australian psychiatrists. Aust. N. Z. J. Psychiatry 33 (1999) 642-649
15. Hyman S.E., and Nestler E.J. Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am. J. Psychiatry 153 (1996) 151-162
16. Hyttel J. Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog. Neuropsychopharmacol. Biol. Psychiatry 6 (1982) 277-295
17. King J.A., Abend S., and Edwards E. Genetic predisposition and the development of posttraumatic stress disorder in an animal model, Biol. Psychiatry 50 (2001) 231-237
18. Lachman H.M., Papolos D.F., Weiner E.D., Ramazankhana R., Hartnick C., Edwards E., and Henn F.A. Hippocampal neuropeptide Y mRNA is reduced in a strain of learned helpless resistant rats. Brain Res. Mol. Brain Res. 14 (1992) 94-100
19. Mayberg H.S., Brannan S.K., Tekell J.L., Silva J.A., Mahurin R.K., McGinnis S., and Jerabek P.A. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol. Psychiatry 48 (2000) 830-843
20. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Mahurin R.K., Jerabek P.A., Silva J.A., Tekell J.L., Martin C.C., Lancaster J.L., and Fox P.T. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am. J. Psychiatry 156 (1999) 675-682
21. McCulloch J., Savaki H.E., and Sokoloff L. Influence of dopaminergic systems on the lateral habenular nucleus of the rat. Brain Res. 194 (1980) 117-124
22. Morris J.S., Smith K.A., Cowen P.J., Friston K.J., and Dolan R.J. Covariation of activity in habenula and dorsal raphe nuclei following tryptophan depletion. Neuroimage 10 (1999) 163-172
23. Nurnberg H.G., Thompson P.M., and Hensley P.L. Antidepressant medication change in a clinical treatment setting: a comparison of the effectiveness of selective serotonin reuptake inhibitors. J. Clin. Psychiatry 60 (1999) 574-579
24. Olfson M., and Marcus S.C. National patterns in antidepressant medication treatment. Arch. Gen. Psychiatry 66 (2009) 848-856
25. Patel J.G., Bartoszyk G.D., Edwards E., and Ashby Jr. C.R. The highly selective 5-hydroxytryptamine (5-HT)2A receptor antagonist, EMD 281014, significantly increases swimming and decreases immobility in male congenital learned helpless rats in the forced swim test. Synapse 52 (2004) 73-75
26. Pizzolato G., Soncrant T.T., and Rapoport S.I. Haloperidol and cerebral metabolism in the conscious rat: relation to pharmacokinetics. J. Neurochem. 43 (1984) 724-732
27. Porsolt R.D., Le Pichon M., and Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 266 (1977) 730-732
28. Prisco S., and Esposito E. Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area. Br. J. Pharmacol. 116 (1995) 1923-1931
29. Roiser J.P., Levy J., Fromm S.J., Nugent A.C., Talagala S.L., Hasler G., Henn F.A., Sahakian B.J., and Drevets W.C. The effects of tryptophan depletion on neural responses to emotional words in remitted depression, Biol. Psychiatry 66 (2009) 441-450
30. Sakata J.T., Crews D., and Gonzalez-Lima F. Behavioral correlates of differences in neural metabolic capacity. Brain Res. Brain Res. Rev. 48 (2005) 1-15
31. Sekine Y., Suzuki K., Ramachandran P.V., Blackburn T.P., and Ashby Jr. C.R. Acute and repeated administration of fluoxetine, citalopram, and paroxetine significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study. Synapse 61 (2007) 72-77
32. Shumake J., Barrett D., and Gonzalez-Lima F. Behavioral characteristics of rats predisposed to learned helplessness: reduced reward sensitivity, increased novelty seeking, and persistent fear memories. Behav. Brain Res. 164 (2005) 222-230
33. Shumake J., Conejo-Jimenez N., Gonzalez-Pardo H., and Gonzalez-Lima F. Brain differences in newborn rats predisposed to helpless and depressive behavior. Brain Res. 1030 (2004) 267-276
34. Shumake J., Edwards E., and Gonzalez-Lima F. Hypermetabolism of paraventricular hypothalamus in the congenitally helpless rat. Neurosci. Lett. 311 (2001) 45-48
35. Shumake J., Edwards E., and Gonzalez-Lima F. Dissociation of septo-hippocampal metabolism in the congenitally helpless rat. Neuroscience 114 (2002) 373-377
36. Shumake J., Edwards E., and Gonzalez-Lima F. Opposite metabolic changes in the habenula and ventral tegmental area of a genetic model of helpless behavior. Brain Res. 963 (2003) 274-281
37. Shumake J., and Gonzalez-Lima F. Brain systems underlying susceptibility to helplessness and depression. Behav. Cogn. Neurosci. Rev. 2 (2003) 198-221
38. Shumake J., Ilango A., Scheich H., Wetzel W., and Ohl F.W. Differential neuromodulation of acquisition and retrieval of avoidance learning by the lateral habenula and ventral tegmental area. J. Neurosci. 30 (2010) 5876-5883
39. Shumake J., Poremba A., Edwards E., and Gonzalez-Lima F. Congenital helpless rats as a genetic model for cortex metabolism in depression. NeuroReport 11 (2000) 3793-3798
40. Skelin I., Sato H., Kovacevic T., and Diksic M. Chronic therapy with citalopram decreases regional cerebral glucose utilization in OBX, and not sham-operated, rats: an autoradiographic study. Psychopharmacology (Berl) 207 (2009) 315-323
41. Vazquez-Palacios G., Bonilla-Jaime H., and Velazquez-Moctezuma J. Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with fluoxetine. Pharmacol. Biochem. Behav. 78 (2004) 165-169
42. Vollmayr B., Bachteler D., Vengeliene V., Gass P., Spanagel R., and Henn F. Rats with congenital learned helplessness respond less to sucrose but show no deficits in activity or learning. Behav. Brain Res. 150 (2004) 217-221
43. Wechsler L.R., Savaki H.E., and Sokoloff L. Effects of d- and l-amphetamine on local cerebral glucose utilization in the conscious rat. J. Neurochem. 32 (1979) 15-22
44. Wooten G.F., and Collins R.C. Metabolic effects of unilateral lesion of the substantia nigra. J. Neurosci. 1 (1981) 285-291